145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

New FDA Approvals

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for han...View more